Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- RTI International
- Study ID
- NCT06385886
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Linkage Coordinator — BEHAVIORALThe Linkage Coordinator (LC) will be the initial contact with unaffiliated SCD patients to establish a relationship, champion preventative services, and support them in engaging with an SCD specialist by helping patients address barriers to care. Study staff will provide initial and ongoing training to the LC to ensure they have adequate support to effectively engage with patients.
Study Details
The goal of this observational study is to help us understand more about the best ways to help individuals living with Sickle Cell Disease (SCD) get the best care. The main question it aims to answer is: How to find individuals unaffiliated from SCD specialist care use three distinct pathways? Once unaffiliated individuals are found using the pathways, Investigators will employ linkage coordinators (trained staff) to engage these patients in care. Participants will be asked to fill out an assessment survey which will cover areas such as previous and current treatment, clinic and hospital experience, pain, and quality of life. Participants will also be given the option of participation in a 1-hour long interview how they feel about treatment for sickle cell disease including clinic experience, pain, and quality of life?
Key Dates
- Start date
- Jun 8, 2023
- Status verified
- Jun 2025
- Primary completion
- Oct 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 500 participants (estimated)
Arms
- Arm: Individuals diagnosed with Sickle Cell Disease (SCD) but not receiving care from an SCD specialist.Individuals diagnosed with Sickle Cell Disease (SCD) but unaffiliated from SCD specialist care. These individuals will be connected to a linkage coordinator (trained staff) to provide a patient-centered approach to engagement with SCD specialist care.
Primary Outcome Measure
Identification of unaffiliated patients [ Time Frame: Beginning of enrollment - end of study (up to 5 years) ]
Central Contacts
- Lisa A Cox, MS770-407-4908
- Sara Jacobs, PhD770-407-4951
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama, Birmingham (UAB) | Birmingham | Alabama | 35233 | |
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | |
| University of California, San Francisco (UCSF) | Oakland | California | 94609 | |
| Augusta University | Augusta | Georgia | 30901 | |
| University of Illinois | Chicago | Illinois | 60612 | |
| Cleveland Clinic | Cleveland | Ohio | 44195 | |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | |
| University of Tennessee at Memphis | Memphis | Tennessee | 38163 | |
| University of Texas at Houston | Houston | Texas | 77030 |
Find similar trials in Birmingham, AL
Related Studies
- Study of Panobinostat (LBH589) in Patients With Sickle Cell DiseasePHASE1 · Recruiting · Abdullah Kutlar · Augusta, Georgia
- Sickle Cell Clinical Research and Intervention ProgramRecruiting · St. Jude Children's Research Hospital · Peoria, Illinois
- Arginine Therapy for the Treatment of Pain in Children With Sickle Cell DiseasePHASE1/PHASE2 · Recruiting · Emory University · Atlanta, Georgia
- Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell DiseasePHASE2 · Recruiting · New York Medical College · Los Angeles, California